Graphenano Medical Care investigates graphene as an intestinal fat adsorbent to reduce obesity


Graphenano Medical Care, a subsidiary of Graphenano Nanotechnologies, has carried out several studies that suggest that graphene works as an intestinal fat adsorbent. Researchers consider that it could be a promising oral therapy to treat diseases such as obesity or fatty liver.

After four years of work led by doctors Manuel Rodríguez and Diego Rodríguez Puyol, from the University of Alcalá de Henares, Graphenano Medical Care has managed to become the first company in the world to patent a functionalized graphene for medical and aesthetic use under the brand name commercial ‘BioGraph’.

Graphene is a material with many applications in very different fields. It is 200 times stronger than steel, flexible, conductive, transparent, light and ecological. It is a much better conductor than copper and 100,000 times finer than human hair. Rodríguez stressed that ‘BioGraph’ “is pure carbon, without pollutants, which is obtained through its own processes and organic gases”.

The researchers explained that they have already submitted the application of ‘Biograph’ as ​​an intestinal absorbent to the European Patent Office, so that in a short period of time it could be used “to reduce weight gain”, since it “makes the fat by a modification of the biology of those cells “. In addition, they have ensured that it is a “very promising” way to treat other diseases such as steatosis of the liver or kidney failure.


Another field in which Graphenano Medical Care is investigating is the application of ‘Biograph’ in dialysis patients. “We have seen that the time of dialysis treatment to purify the blood is reduced, but we are still in very preliminary stages and other parameters must be studied,” they pointed out.

Researchers at the University of Alcalá de Henares are also completing different studies on the role of ‘BioGraph’ as ​​a regenerator of muscles, a therapy that could be very relevant especially for athletes. However, according to the authors, “we must first see in which specific cases it could be used.”

The use of graphene to accelerate wound healing or to treat the regeneration of the retina are other applications that are being studied by experts, although still at a very early stage.

The authors have celebrated that in recent years “scientific production has increased exponentially” on graphene in the field of medicine and has predicted a “very promising” future for this mineral in the sector. “We are very interested in a very exciting project with ‘BioGraph’ and other products developed by Graphenano Medical Care in ophthalmological applications, specifically in the treatment of retinal regeneration”, they have concluded.


In addition to the medical field, graphene also has multiple properties in the area of ​​aesthetics. The incorporation of ‘BioGraph’ in cosmetic products for topical use confers numerous benefits to the final product, such as an antioxidant and moisturizing action, firmness and elasticity, since it reduces transdermal water loss.

It is also “a powerful ‘fat burner’ and cellulite reducer due to its high lipolytic efficacy, also promoting microcirculation”, as explained by the technical director of Graphenano Medical Care, Aida Lacasa.

‘Graphenano’ already markets cosmetic products through its AcquaGraph * brand, such as anti-aging day and night moisturizers, serums or anti-cellulite. “We are obtaining optimal results in the area of ​​medical devices, nutritional supplements and aesthetic medicine,” he concluded.